Home  »  Trending   »  Repligen Corporation (RGEN): Skating on Thin Ice? ...

Repligen Corporation (RGEN): Skating on Thin Ice? We Know the Answer

Repligen Corporation (NASDAQ:RGEN) went up by 11.68% from its latest closing price compared to the recent 1-year high of $327.32. The company’s stock price has collected 17.51% of gains in the last five trading sessions.

Is It Worth Investing in Repligen Corporation (NASDAQ :RGEN) Right Now?

Repligen Corporation (NASDAQ:RGEN) scored a price-to-earnings ratio above its average ratio, recording 94.05 x from its present earnings ratio. Plus, the 36-month beta value for RGEN is at 1.05. Opinions of the stock are interesting as 9 analysts out of 10 who provided ratings for Repligen Corporation declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

The average price from analysts is $236.89, which is -$0.49 below the current price. RGEN currently public float of 51.70M and currently shorts hold a 6.09% ratio of that float. Today, the average trading volume of RGEN was 489.74K shares.

RGEN’s Market Performance

RGEN stocks went up by 17.51% for the week, with a monthly jump of 42.55% and a quarterly performance of 49.46%, while its annual performance rate touched -4.23%. The volatility ratio for the week stands at 5.64% while the volatility levels for the past 30 days are set at 4.84% for Repligen Corporation. The simple moving average for the period of the last 20 days is 29.31% for RGEN stocks with a simple moving average of 17.86% for the last 200 days.

Analysts’ Opinion of RGEN

Many brokerage firms have already submitted their reports for RGEN stocks, with UBS repeating the rating for RGEN by listing it as a “Buy.” The predicted price for RGEN in the upcoming period, according to UBS is $213 based on the research report published on July 20th of the current year 2022.

Exane BNP Paribas, on the other hand, stated in their research note that they expect to see RGEN reach a price target of $330. The rating they have provided for RGEN stocks is “Outperform” according to the report published on October 14th, 2021.

KeyBanc Capital Markets gave a rating of “Overweight” to RGEN, setting the target price at $241 in the report published on November 10th of the previous year.

RGEN Trading at 41.12% from the 50-Day Moving Average

After a stumble in the market that brought RGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.48% of loss for the given period.

Volatility was left at 4.84%, however, over the last 30 days, the volatility rate increased by 5.64%, as shares surge +41.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +53.51% upper at present.

During the last 5 trading sessions, RGEN rose by +17.51%, which changed the moving average for the period of 200-days by -11.61% in comparison to the 20-day moving average, which settled at $187.06. In addition, Repligen Corporation saw -10.37% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at RGEN starting from Snodgres Jon, who sale 2,000 shares at the price of $220.00 back on Aug 01. After this action, Snodgres Jon now owns 37,187 shares of Repligen Corporation, valued at $440,000 using the latest closing price.

Hunt Anthony, the Chief Executive Officer of Repligen Corporation, sale 24,802 shares at $200.00 during a trade that took place back on Jul 21, which means that Hunt Anthony is holding 194,667 shares at $4,960,400 based on the most recent closing price.

Stock Fundamentals for RGEN

Current profitability levels for the company are sitting at:

  • +28.82 for the present operating margin
  • +55.62 for the gross margin

The net margin for Repligen Corporation stands at +19.13. Equity return is now at value 8.50, with 6.50 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 2.48.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]